tweenvest

Vector Science and Therapeutics Corp. (TSXV: PAIN)

Health Care · Biotechnology · US

CA$2.80

+16.67% today · +656.8% 1Y

Public summary
A free snapshot of Vector Science and Therapeutics Corp., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Vector Science and Therapeutics Corp. (TSXV: PAIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $307.08M.

Over the last twelve months the share price has gained 656.8%, trading between 0.35 and 2.80.

Tweenvest scores Vector Science and Therapeutics Corp. across four factors: quality 74/100. Its strongest factor is quality.

PAIN price history

May 1, 2026 · 0.60Weekly closes 0.60 – 2.80Nov 12, 2026 · 2.80

Key figures

Market cap
$307.08M
Revenue (TTM)
—
P/E
—
EPS
-0.18
Dividend yield
—
Beta (5Y)
4.76
52-week high
CA$2.80
52-week low
CA$0.35
Avg volume (3M)
—
Shares outstanding
156.36M
Employees
—
Next earnings
—

About Vector Science and Therapeutics Corp.

Vector Science & Therapeutics Corp. engages in the development of novel biomechanical devices and active transdermal drug and peptide delivery platforms. It equips clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm. The company was founded on April 30, 2021 and is headquartered in Mequon, WI.

ISIN
CA92244M1041
Listed since
Apr 28, 2026
Exchange
TSX Venture Exchange
Currency
CAD
CompanyMarket capPriceDay
Benitec Biopharma Inc.NasdaqCM: BNTC$317.08M$9.09-4.01%
OBI Pharma, Inc.TPEX: 4174$312.93MNT$78.40+9.96%
Scribe Therapeutics Inc.NasdaqGM: SCTX$309.82M$16.36-3.71%
Galectin Therapeutics Inc.NasdaqCM: GALT$307.59M$3.05-2.87%
Jiangsu Recbio Technology Co., Ltd.SEHK: 2179$306.59MHK$3.900.00%
HJ Science Co., Ltd.SEHK: 6132$304.32MHK$32.44-2.99%
Kyverna Therapeutics, Inc.NasdaqGS: KYTX$300.94M$4.76-5.74%
Vicore Pharma Holding AB (publ)OM: VICO$299.86MSkr10.72-2.37%

Browse every Biotechnology company →